Key facts
- It has raised $35.0M; the latest was Later Stage VC ($35.0M) in Apr 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Incinta
- ·The full record, as it builds
Funding rounds
No funding rounds for Incinta are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Incinta
Operator of a medical investment and medical institution management platform. The company's platform focuses on providing assisted reproduction technology, genetic diagnosis, and tumor precision medical treatment at home and abroad.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2012
- Website
- incinta.cn/
- Ownership
- Privately Held (backing)
Incinta doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Incinta shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Incinta in its N-PORT filings yet. We sweep new filings monthly.